Prediction of resistance to bevacizumab plus FOLFOX in metastatic colorectal cancer using a multi-marker panel and a machine-learning approach: Final results of the prospective multicenter PERMAD trial.
| Autor: | Kestler, Hans A., Ettrich, Thomas Jens, Stein, Alexander, Arnold, Dirk, Prager, Gerald W., Kasper, Stefan, Niedermeier, Michael, Müller, Lothar, Kubicka, Stefan, Koenig, Alexander, Buechner-Steudel, Petra, Berger, Andreas, Wille, Kai, Kestler, Angelika, Kraus, Johann M., Werle, Silke, Perkhofer, Lukas, Lausser, Ludwig, Seufferlein, Thomas |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 2024 Supplement 3, Vol. 42, p204-204, 235p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|